USD 0.4
(0.0%)
Breakdown | 2023 | 2020 | 2019 | 2018 | 2017 | 2016 |
---|---|---|---|---|---|---|
Operating Cash Flow | -9660.00 | -8.75 | -27.78 Thousand | -51.19 Thousand | 18.01 | -636.72 Thousand |
Net Income | 192.65 Thousand | -17.16 Thousand | -1.39 Million | -99.93 Thousand | -50.63 | 24.85 Thousand |
Depreciation & Amortization | - | - | - | 2500.00 | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | 17.11 Thousand | 1306.35 | - | - | - |
Change in working capital | 29.3 Thousand | -1.75 | 21.62 Thousand | 46.24 Thousand | 123.64 | -661.57 Thousand |
Other non-cash items | -231.62 Thousand | 43.36 | 1.34 Million | -26.96 Thousand | -55.00 | 661.57 Thousand |
Investing Cash Flow | - | - | - | - | - | 696.58 Thousand |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | 664 Thousand |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | 32.58 Thousand |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | 9660.00 | 8.75 | 27.78 Thousand | 51.33 Thousand | -20.50 | - |
Debt repayment | -9660.00 | - | -27.78 Thousand | -36.16 Thousand | -20.50 | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | 8.75 | 27.78 | 15.17 Thousand | - | - |
Accounts receivables | - | - | - | -88.00 | 80.00 | -727.29 Thousand |
Accounts payables | - | - | - | 6826.00 | - | -29.28 Thousand |
Inventory | - | - | - | 25.22 Thousand | - | 95 Thousand |
Other working capital | 29.3 Thousand | -1.75 | 21.62 Thousand | 14.28 Thousand | 43.64 | - |
Cash at beginning of period | - | - | 138.00 | 2518.00 | - | 30 Thousand |
Cash at end of period | - | - | 138.00 | 138.00 | -2.50 | 2496.00 |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | - | -2380.00 | -2.50 | -27.5 Thousand |
Free Cash Flow | -9660.00 | -8.75 | -27.78 Thousand | -51.19 Thousand | 18.01 | -636.72 Thousand |
Breakdown | 2023 FY | 2021 Q1 | 2020 FY | 2020 Q3 | 2020 Q1 | 2019 FY |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 192.65 Thousand | -71.72 | -17.16 Thousand | 89.53 Thousand | -5.28 | -1.39 Million |
Depreciation & Amortization | - | - | - | 1250.00 | 1.25 | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | 17.11 Thousand | - | - | 1306.35 |
Change in working capital | 29.3 Thousand | 1.75 | -1.75 | 1604.48 | - | 21.62 Thousand |
Other non-cash items | -231.62 Thousand | 53.07 | 43.36 | -97.48 Thousand | 4.03 | 1.34 Million |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | 9660.00 | 16.90 | 8.75 | 7601.24 | - | 27.78 Thousand |
Debt repayment | -9660.00 | - | - | -7601.24 | - | -27.78 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | 16.90 | 8.75 | - | - | 27.78 |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 29.3 Thousand | 1.75 | -1.75 | 1604.48 | - | 21.62 Thousand |
Cash at beginning of period | - | - | - | - | - | 138.00 |
Cash at end of period | - | - | - | - | - | 138.00 |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | - | - | - | - |
Free Cash Flow | -9660.00 | -16.90 | -8.75 | -7601.24 | - | -27.78 Thousand |
XGC
NATHBIOGEN
SYTIXSE
DC-A
000995
WEGZY